Osaka University Graduate School of Medicine and others have completed clinical trials of the RH-01 rehabilitation system, which provides online monitoring.
The system has been licensed to Remohab (Osaka City, President Tatsunori Taniguchi), a medical device startup company spun out of Osaka University, and they have applied for pharmaceutical approval for the remote cardiac rehabilitation system.
Heart disease is the second leading cause of death in Japan. Cardiac rehabilitation, one of the important treatments for heart disease, prescribes exercise therapy with a load and frequency suited to each patient based on data such as blood pressure and electrocardiogram waveforms, and is said to produce stable results by performing the therapy at least three times a week.

※Translating Japanese articles into English with AI